575 related articles for article (PubMed ID: 15623264)
1. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
2. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
Tannenbaum H; Bombardier C; Davis P; Russell AS;
J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
[TBL] [Abstract][Full Text] [Related]
3. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
6. Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.
Greenberg JD; Bingham CO; Abramson SB; Reed G; Kishimoto M; Hinkle K; Kremer J
Arthritis Rheum; 2006 Aug; 55(4):543-50. PubMed ID: 16874798
[TBL] [Abstract][Full Text] [Related]
7. Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.
Shireman TI; Rigler SK
Am J Geriatr Pharmacother; 2006 Sep; 4(3):210-8. PubMed ID: 17062321
[TBL] [Abstract][Full Text] [Related]
8. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.
Patino FG; Allison J; Olivieri J; Mudano A; Juarez L; Person S; Mikuls TR; Moreland L; Kovac SH; Saag KG
Arthritis Rheum; 2003 Jun; 49(3):293-9. PubMed ID: 12794782
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
Moore RA; Derry S; Phillips CJ; McQuay HJ
BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
[TBL] [Abstract][Full Text] [Related]
10. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
11. Concordance with guideline recommendations: previous and more recent nonsteroidal anti-inflammatory drug prescriptions in Quebec, Canada.
Rahme E; Roussy JP; Lafrance JP; Nedjar H; Morin S
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):420-7. PubMed ID: 22223535
[TBL] [Abstract][Full Text] [Related]
12. A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders.
Klein D; MacDonald A; Drummond N; Cave A
Fam Pract; 2006 Dec; 23(6):659-65. PubMed ID: 17035286
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in NSAID use among older adults with osteoarthritis.
Dominick KL; Ahern FM; Gold CH; Heller DA
Ann Pharmacother; 2003 Nov; 37(11):1566-71. PubMed ID: 14565813
[TBL] [Abstract][Full Text] [Related]
14. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
Chan FK; Abraham NS; Scheiman JM; Laine L;
Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
[TBL] [Abstract][Full Text] [Related]
15. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors.
Schneeweiss S; Glynn RJ; Avorn J; Solomon DH
J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677
[TBL] [Abstract][Full Text] [Related]
16. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients.
Solomon DH; Glynn RJ; Bohn R; Levin R; Avorn J
J Rheumatol; 2003 Apr; 30(4):792-8. PubMed ID: 12672201
[TBL] [Abstract][Full Text] [Related]
17. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
Hur C; Chan AT; Tramontano AC; Gazelle GS
Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
[TBL] [Abstract][Full Text] [Related]
18. Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.
Sukel MP; van der Linden MW; Chen C; Erkens JA; Herings RM
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):9-19. PubMed ID: 17963198
[TBL] [Abstract][Full Text] [Related]
19. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
20. Management pattern for patients with osteoarthritis treated with traditional non-steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs.
Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
Curr Med Res Opin; 2003; 19(4):278-87. PubMed ID: 12841920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]